医学
内科学
回顾性队列研究
心脏病学
肌钙蛋白I
肌钙蛋白
价值(数学)
队列研究
队列
冲程(发动机)
预测值
试验预测值
缺血
再灌注治疗
心肌梗塞
缺血性中风
多中心研究
急性中风
疾病严重程度
肌钙蛋白T
心电图
脑缺血
作者
Andrea Loggini,Camila Bonin Pinto,Heather Von Hagn,Laura Boada Robayo,Amber Schwertman,Kaitlyn Pixley,Michiaki Nagai,Ayesha Sajid,Trace Lawson,Faddi Ghassan Saleh Vélez
标识
DOI:10.1080/00207454.2025.2589395
摘要
BACKGROUND: We aimed to evaluate the association between elevated cardiac troponin I (cTnI) and clinical outcomes in AIS patients receiving reperfusion therapy. METHODS: We conducted a multicenter retrospective cohort study of AIS patients treated with thrombolytics at Southern Illinois Healthcare and the University of Oklahoma (2017-2024). Demographic, clinical, laboratory, and radiographic data were collected. Elevation of cTnI was defined as levels above 0.028 ng/mL. For high sensitivity troponins, the cutoff was 15 ng/L for women and 20 ng/L for men. Outcomes included symptomatic intracranial hemorrhage (sICH), in-hospital mortality, and functional status at 30 days (good outcome defined as mRS ≤2). Overlap-weighted multivariable logistic regression was performed, adjusting for demographics, comorbidities, and stroke severity. RESULTS: > 0.05). CONCLUSIONS: In our study, elevated cTnI on admission is an independent predictor of poor short-term outcomes in AIS patients treated with reperfusion therapy. Troponin measurement may provide important prognostic information, particularly in older patients and those with more severe strokes.
科研通智能强力驱动
Strongly Powered by AbleSci AI